{"id":"W2155419282","doi":"10.6000/1927-7229.2014.03.01.9","title":"99mTc-Labeled Bevacizumab via HYNIC for Imaging of Melanoma","year":2014,"lang":"en","type":"article","venue":"Journal of Analytical Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Bevacizumab; Biodistribution; In vivo; Imaging agent; Medicine; Vascular endothelial growth factor; Melanoma; Cancer research; Nuclear medicine; Pathology; Chemotherapy; Internal medicine; VEGF receptors; Biology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001498453,0.000288771,0.0002119237,0.0002189476,0.00008065216,0.0001932815,0.000216605,0.0004293122,0.0009843863],"category_scores_gemma":[0.0001053666,0.0001754387,0.0001473054,0.0001928544,0.000121862,0.0002069715,0.0001715632,0.0003994956,0.000275728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003262099,"about_ca_system_score_gemma":0.0001645663,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007430607,"about_ca_topic_score_gemma":0.0009520806,"domain_scores_codex":[0.9999164,0.00002714838,0.000003218237,0.00002129225,0.00001719914,0.00001475329],"domain_scores_gemma":[0.9999614,0.000005286567,0.00001160086,0.000003930198,0.000009428072,0.000008415214],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007529285,0.000009822487,0.0001002821,0.00004855359,0.000004365637,0.00003378585,0.000005200952,0.00007031591,0.9978679,0.00008237887,0.00005107343,0.001650964],"study_design_scores_gemma":[0.00002377548,0.0004091661,0.001310778,0.00001190111,0.00003137357,0.0006623534,0.000008243922,0.003283703,0.9894139,0.0000444662,0.004793101,0.000007145858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9204701,0.01300655,0.0569439,0.0003149894,0.00009758551,0.0001729711,0.0003934555,0.0003726464,0.008227753],"genre_scores_gemma":[0.9533362,0.003318147,0.0366671,0.0001384426,0.0000263569,0.00008343773,0.0005644037,0.00005310163,0.005812809],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009843863,"threshold_uncertainty_score":0.003293157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02872070771675659,"score_gpt":0.3864361374847682,"score_spread":0.3577154297680116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}